AI in Computer-Aided Synthesis Planning Market reached USD 2.13 bn in 2024 and is expected to grow rapidly to USD 68.06 bn by ...
According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...
Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex ...
Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.
Explore AI funding trends beyond Silicon Valley. Discover investments spanning biotech & enterprise software, to alcohol & ...
This year, cross-border deals in China’s innovative drug sector have accelerated, with artificial intelligence -driven firms ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results